Cargando…
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
BACKGROUND: Remdesivir is efficacious for severe coronavirus disease 2019 (COVID-19) in adults, but data in pregnant women are limited. We describe outcomes in the first 86 pregnant women with severe COVID-19 who were treated with remdesivir. METHODS: The reported data span 21 March to 16 June 2020...
Autores principales: | Burwick, Richard M, Yawetz, Sigal, Stephenson, Kathryn E, Collier, Ai-Ris Y, Sen, Pritha, Blackburn, Brian G, Kojic, E Milunka, Hirshberg, Adi, Suarez, Jose F, Sobieszczyk, Magdalena E, Marks, Kristen M, Mazur, Shawn, Big, Cecilia, Manuel, Oriol, Morlin, Gregory, Rose, Suzanne J, Naqvi, Mariam, Goldfarb, Ilona T, DeZure, Adam, Telep, Laura, Tan, Susanna K, Zhao, Yang, Hahambis, Tom, Hindman, Jason, Chokkalingam, Anand P, Carter, Christoph, Das, Moupali, Osinusi, Anu O, Brainard, Diana M, Varughese, Tilly A, Kovalenko, Olga, Sims, Matthew D, Desai, Samit, Swamy, Geeta, Sheffield, Jeanne S, Zash, Rebecca, Short, William R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797739/ https://www.ncbi.nlm.nih.gov/pubmed/33031500 http://dx.doi.org/10.1093/cid/ciaa1466 |
Ejemplares similares
-
Vaccines for Emerging Viral Diseases
por: DeZure, Adam, et al.
Publicado: (2016) -
Compassionate Use of Remdesivir for Patients with Severe Covid-19
por: Grein, Jonathan, et al.
Publicado: (2020) -
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants
por: Humeniuk, Rita, et al.
Publicado: (2023) -
476. Gilead Sciences’ Commitment to the COVID-19 Pandemic
por: Lee, EunYoung, et al.
Publicado: (2020) -
Do Positive Anaerobic Culture Results Affect Physicians’ Clinical Management Decisions?
por: Bhowmick, Tanaya, et al.
Publicado: (2017)